Description

Correlation analyses between symptom improvement and microbiota changes are presented from the synbiotic IBS-D trial.

Figure 29

Chart

Source Paper

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …

Nutrients (2020)

PMID: 32635661

DOI: 10.3390/nu12071999

Cite This Figure

![Figure 29: Correlation analyses between symptom improvement and microbiota changes are presented from the synbiotic IBS-D trial.]()

> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)

<figure>
  <img src="" alt="Correlation analyses between symptom improvement and microbiota changes are presented from the synbiotic IBS-D trial." />
  <figcaption>Figure 29. Correlation analyses between symptom improvement and microbiota changes are presented from the synbiotic IBS-D trial.<br>  Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption>
</figure>

Preuves associées

Bifidobacterium longum pour Irritable Bowel Syndrome (IBS)

Note B · 4 études

Galactooligosaccharides (GOS) pour Irritable Bowel Syndrome (IBS)

Note B · 3 études

Lactobacillus acidophilus pour Irritable Bowel Syndrome (IBS)

Note B · 3 études

Fructooligosaccharides (FOS) pour Irritable Bowel Syndrome (IBS)

Note D · 2 études